FIELD: medicine.
SUBSTANCE: invention describes a method for prediction of clinical effectiveness in glucocorticoids-treated multiple sclerosis by blood examination wherein blood is analysed for absolute apoptotic lymphocyte count; a programmed cell death realisation index (%) is calculated prior to, during and after the treatment by formula, and if observing the increase of the apoptosis realisation index (ARI) after glucocorticoid treatment in relation to its initial values, the treatment is considered to be effective, while the absence of dynamics enabled to predict a negative efficacy of the hormonal therapy.
EFFECT: more precise estimation of clinical effectiveness in multiple sclerosis by a laboratory method.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING CLINICAL COURSE OF DISSEMINATED SCLEROSIS | 2005 |
|
RU2272292C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR REMITTENT AND SECONDARY-PROGRESSIVE MULTIPLE SCLEROSIS | 2010 |
|
RU2428693C1 |
| METHOD OF THERAPY OF REMITTENT MULTIPLE SCLEROSIS | 2012 |
|
RU2523058C2 |
| METHOD FOR PREDICTING TRANSFORMATION OF CHRONIC DISSEMINATED ENCEPHALOMYELITIS IN MULTIPLE SCLEROSIS IN CHILDREN | 2020 |
|
RU2740243C1 |
| TREATMENT OF REMITTENT DISSEMINATED SCLEROSIS | 2005 |
|
RU2278687C1 |
| METHOD FOR CORRECTION OF VEGETATIVE SYMPTOM OF CLIMACTERIC SYNDROME IN WOMEN WITH ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2005 |
|
RU2282445C1 |
| METHOD OF REHABILITATION OF MULTIPLE SCLEROSIS PATIENTS WITH DISORDERED MOTOR FUNCTION | 2008 |
|
RU2393843C1 |
| METHOD FOR TREATING DISSEMINATED SCLEROSIS | 1991 |
|
RU2016568C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CNS ORGANIC LESIONS IN CHILDREN DURING THE ACUTE PERIOD | 2017 |
|
RU2648215C1 |
| METHOD FOR TREATING DISSEMINATED SCLEROSIS | 0 |
|
SU1821214A1 |
